Atlas Trials

Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP)

Clinical trial NCT00450385 · TERMINATED

Trial details

NCT number
NCT00450385
Sponsor
University of Miami
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2007-04-24
Primary completion
2016-05-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.